Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area

Sourabh Verma1,2, Rishi Lumba3, Heda M Dapul3,2

  • 1Departments of Pediatrics and sourabh.verma@nyulangone.org.

Hospital Pediatrics
|October 9, 2020
PubMed

Insights

Hospitalized children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in NYC faced critical care needs, especially those with comorbidities like obesity and asthma. Renal dysfunction also predicted critical care admission.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a global pandemic in 2020.
  • Pediatric hospitalizations due to SARS-CoV-2 required characterization to inform clinical management.
  • Understanding risk factors for severe disease in children is crucial for public health strategies.

Purpose of the Study:

  • To describe the clinical characteristics of hospitalized children diagnosed with SARS-CoV-2.
  • To identify risk factors associated with critical care admission and respiratory support needs in pediatric patients.
  • To analyze the impact of comorbidities and renal dysfunction on disease severity.

Main Methods:

  • A multicenter, retrospective cohort study was conducted.
  • Included 82 hospitalized children (0-21 years) with confirmed SARS-CoV-2 infection.
  • Patients were analyzed based on care unit, age, and need for respiratory support.

Main Results:

  • 28% of hospitalized children required critical care, and 35% needed respiratory support (9% mechanical ventilation).
  • Comorbidities, particularly obesity and asthma, were linked to increased critical care and respiratory support.
  • Renal dysfunction at presentation was associated with higher critical care admission rates.

Conclusions:

  • Children with comorbidities, especially obesity and asthma, face a higher risk of severe SARS-CoV-2 disease.
  • Renal dysfunction is a significant predictor of critical care needs in pediatric SARS-CoV-2 patients.
  • All studied pediatric patients survived hospitalization, highlighting the importance of timely medical intervention.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
840
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
670
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
332
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
616
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
577
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K